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ABSTRACT 8 
The global spread of KPC carbapenemase-producing Klebsiella pneumoniae has been mainly 9 
associated with the dissemination of high-risk clones. Most of the hospital outbreaks 10 
reported in the last decade have been attributed to isolates belonging to Clonal Group 258. 11 
However, recent epidemiological analysis suggests that a new clone, sequence type (ST) 12 
307, is emerging in different parts of the world and is a candidate to become one of the 13 
most prevalent high-risk clones in the near future. Here we show that the ST307 genome 14 
encodes features that can provide an advantage in adaptation in the hospital environment 15 
and in the human host. These include novel plasmid-located virulence clusters, such as a 16 
cluster for glycogen synthesis. Glycogen production is considered one of the possible 17 
adaptive responses to long-term survival and growth in environments outside the host. 18 
Chromosomally-encoded virulence traits, including fimbriae, an Integrative Conjugative 19 
Element carrying the yersiniabactin siderophore, and two different capsular loci were 20 
identified. Resistance to complement was verified in capsulated and uncapsulated ST307 21 
strains.  The acquired genetic features identified in the genome of this new emerging clone 22 
may contribute to increased persistence of ST307 in the hospital environment, and shed 23 
light on its potential epidemiological success. 24 
 25 
 26 
DATA SUMMARY 27 
 28 
1. Whole Genome Shotgun project KP48-IT has been released at DDBJ/ENA/GenBank, 29 
accession no.: PRJNA295649 (https://www.ncbi.nlm.nih.gov/bioproject/295649) 30 
2. Whole Genome Shotgun project PRJNA354908 has been deposited at DBJ/ENA/GenBank, 31 
accession no. PRJNA354908 (https://www.ncbi.nlm.nih.gov/bioproject/354908), individual 32 
accession numbers are listed in Table S1 33 
3. Novel plasmid nucleotide sequences have been deposited in GenBank, accession 34 
numbers: pKpQIL_307, KY271403; pKPN3_307_typeA, KY271404; pKPN3_307_typeB,  35 
KY271405; pKPN307_TypeC,  KY271406; pKPN3_307_TypeD,  KY271407; IncN_typeA, 36 
KY271413;  IncN_typeB, KY271414; IncN_typeC, KY271415: pTet_ 7201, KY271408 37 
4. The complete DNA sequences of the following prophage genomes have been deposited in 38 
GenBank, accession number: Prophage1_ST307, KY271401; Prophage2_ST307, KY271396; 39 
Prophage2b_ST307, KY271395; Prophage3_ST307, KY271397; Prophage4_ST307, KY271398; 40 
Prophage5_ST307, KY271399; Prophage6_ST307, KY271400; Phage48_ST307, KY271402 41 
5. Type A and Type B Integrative Conjugative Elements have been deposited in GenBank; 42 
accession numbers KY271411 and KY271412, respectively 43 
6. The π-fimbria cluster sequence has been deposited in GenBank, accession number 44 
KY271409 45 
7. The capsula_entero_ST307 cluster sequence has been deposited in GenBank, accession 46 
number KY271410. 47 
 48 
I/We confirm all supporting data, code and protocols have been provided within the 49 
article or through supplementary data files. X 50 
 51 
 52 
IMPACT STATEMENT 53 
Klebsiella pneumoniae is one of the most relevant cause of healthcare-associated infections. 54 
The global spread of carbapenemase-producing Klebsiella pneumoniae high-risk clones is a 55 
concern. Most of the hospital outbreaks reported in the last decade have been attributed to 56 
isolates belonging to Clonal Group 258 but new clones, showing higher mortality and longer 57 
hospital stay can emerge. 58 
Recent epidemiological evidences indicate that a new lineage, sequence type 307, has been 59 
detected in different parts of the world, in some hospitals displacing the CG258. Here we 60 
report the first description of the ST307 genome, studying isolates from different 61 
geographical origin. Resistome and mobilome were fully characterized, by complete 62 
assembly of resistance and virulence plasmids, identifying integrative conjugative elements 63 
associated with the acquisition of the yersiniabactin virulence cluster, and phage content. 64 
ST307 resistance to human sera was measured. 65 
ST307 genome encodes plasmid-located and chromosomally-encoded features that can 66 
provide an advantage in adaptation in the hospital environment and in the human host.  67 
Some of the genetic features described in this study are novel or very rare for Klebsiella spp. 68 
and may help in tracing emergence of ST307 in future surveillance studies performed 69 
around the world.70 
 71 
INTRODUCTION 72 
The worldwide spread of carbapenem-producing Klebsiella pneumoniae (Kp) has become a 73 
major threat for healthcare facilities (Wyres & Holt, 2016). This global phenomenon has 74 
been mainly associated with the clonal dissemination of high-risk clones. One of the most 75 
successful is the KPC-producing Kp (KPC-Kp) sequence type (ST) 258 clone, and its related 76 
variants belonging to Clonal Group 258 (CG258) (Chen et al., 2014; Bowers et al., 2014).  In 77 
recent years new extensively drug-resistant lineages have emerged internationally (Bialek-78 
Davenet et al., 2014; Struve et al., 2015; Wyres & Holt, 2016; Zhou et al., 2016; Ruiz-79 
Garbajosa et al. 2013; Giske et al. 2012). Among them, KPC-Kp ST307 is candidate to 80 
become one of the most relevant clones, since its emergence has been recognized in several 81 
countries in the last five years (Girlich et al., 2014; Castanheira et al., 2013; Gona et al., 82 
2014; Richter et al., 2012). ST307 was first defined in 2008 in the MLST database (an 83 
unpublished isolate), but has since been described in 2013 in the US (Castanheira et al., 84 
2013). It can be hypothesized that ST307 was initially associated with the production of the 85 
globally disseminated extended-spectrum beta-lactamase (ESBL) CTX-M-15. The acquisition 86 
of KPC enzyme was subsequent to that of CTX-M-15, as deduced by the fact that CTX-M-15-87 
producing Kp ST307 were previously reported at high frequencies (70 to 90%) in Italy, Korea, 88 
Pakistan, Morocco and in pets from Japan (Girlich et al., 2014; Castanheira et al., 2013; 89 
Gona et al., 2014; Richter et al., 2012; Habeeb et al., 2013; Harada et al., 2016; Park et al., 90 
2015). 91 
The Italian experience is particularly interesting because it illustrates what might happen 92 
elsewhere in the future, with replacement among KPC producers of CG258 by ST307 in a 93 
short period of time. In fact, the first outbreak of KPC-3-producing Kp ST258 in Palermo, 94 
Sicily occurred in 2008 (Mammina et al., 2010), and then this clone became a key 95 
epidemiological feature of many healthcare facilities in this region until 2013 (Giuffrè et al., 96 
2013). A surveillance study performed in March-August 2014 in the three largest hospitals 97 
of Palermo recognized an epidemiological change, since multifocal dissemination of KPC-3-98 
producing Kp clones was observed. In particular, the predominant KPC-3 CG258 clone was 99 
identified in 38/94 (40%) patients, but in 27/94 (28%) of them were ST307 producing both 100 
KPC-3 and CTX-M-15 was found (Bonura et al., 2015; Geraci et al., 2015).  101 
In Colombia, a two-year surveillance study was performed from June 2012 to June 2014 in 102 
five tertiary-care centers in Medellín, collecting 193 carbapenem-resistant Kp strains. 103 
Remarkably, whilst 62.2% of isolates were from STs unrelated to CG258, whereas 14.2 % of 104 
them were ST307 (Ocampo et al., 2016). Patients infected with KPC-Kp ST307 presented 105 
high mortality (over 50%) and longer hospital stay compared with other clones, supporting 106 
the evidence that this lineage is probably possessing additional factors contributing to its 107 
epidemiological success. Low prevalence is observed by the National Infection Service, 108 
Public Health England in United Kingdom with just eight KPC-Kp ST307 isolates identified in a 109 
collection of >3000 carbapenem-producing Kp isolates from 2014-2016. Interestingly, one of 110 
these strains was from a patient transferred to the UK from Italy.  111 
In this work, we performed whole-genome sequencing (WGS) and compared the genetic 112 
structures of KPC-Kp ST307 isolates from Italy, Colombia, and the UK seeking to identify 113 
factors that contribute to the success and spread of the KPC-Kp ST307 clone. 114 
 115 
 116 
METHODS 117 
Clinical isolates and sequenced strains 118 
A total of 24 ST307 KPC-Kp isolates were studied. Twelve on 27 ST307 KPC-3-Kp isolates 119 
collected during the surveillance study performed in March-August 2014 in Palermo (Bonura 120 
et al., 2015).These were representatives of the isolates obtained from the three 121 
participating hospitals, and were selected on the basis of the slightly different Pulsed-Field 122 
Gel Electrophoresis (PFGE) patterns (defined as D1, D4 subtypes; Bonura et al., 2015; Geraci 123 
et al., 2015). Among the 12 selected strains, seven and five were CTX-M-15 positive or 124 
negative, respectively (Table 1) .  125 
The four Colombian isolates were selected from the collection of 17 KPC-ST307- Kp obtained 126 
during the two-year surveillance study (Ocampo et al., 2016); two strains were KPC-2 and 127 
two KPC-3 positives and came from two different hospitals (Table 1). 128 
The complete genomes of 12 strains were obtained: isolates 48-IT and CIV4-IT were chosen 129 
for WGS from the Italian collection as representatives of the KPC-3, CTX-M-15 positives and 130 
KPC-3-positive, CTX-M-15 negative isolates, respectively.  KL-49-CO and KH-43-CO were 131 
chosen for WGS as representatives of the KPC-2 positive strains from Colombia.  132 
In addition, the short-read genomic data of eight KPC-Kp isolates from the UK and 133 
sequenced by the National Infection Service, Public Health England were also included in the 134 
study (Table 1). These were the only ST307 KPC-Kp isolates among >3000 CPE genomes, and 135 
one of these was from a patient who had been transferred from Italy (strain H155360912-136 
IT). Of these eight KPC-Kp isolates, seven belonged to ST307 and one was a single-locus 137 
variant of ST307 (H154440769-UK).  138 
Whole-Genome sequencing 139 
Strain Genomic DNA was purified from the 48-IT was strain by the Macherey Nagel DNA 140 
extraction kit. Plasmid DNA from the 48-IT was purified using the Plasmid Midi Kit 141 
(Invitrogen). Genomic and plasmid DNA were used to prepare two different shot-gun 142 
libraries and sequenced (Villa et al., 2016) onat the 454-GS platform according tofollowing 143 
the standard sequencing procedure (Roche Diagnostics) Reads obtained were assembled 144 
using the GS-FLX gsAssembler software (Roche Diagnostics). 145 
WGS of strains CIV4-IT, KH-43-CO and KL-49-CO was performed on DNA extracted using the 146 
Macherey Nagel kit. Genomic DNA paired-end libraries were generated using the Nextera XT 147 
DNA sample preparation kit (Illumina Inc, San Diego, CA, USA) and sequenced using the 148 
Illumina MiSeq next generation sequencer with 2x300PE (Illumina Inc). DNA from UK 149 
isolates was extracted with a Qiasymphony DSP (Qiagen).  DNA libraries were prepared 150 
using the Nextera XT sample preparation method and sequenced with a standard 2x100 PE 151 
protocol on a HiSeq 2500 instrument (Illumina). De novo assembly was performed using the 152 
Galaxy version 20150522 of A5 pipeline through the ARIES public Galaxy server 153 
(https://w3.iss.it/site/aries/; Tritt et al., 2012) 154 
Genome annotation and analysis 155 
Draft genomes were ordered using the MAUVE comparison tool against the K. pneumoniae 156 
NJST258_2 (NZ_CP006918), KPNIH1 (NZ_ CP008827) and HS11286 (CP003200), reference 157 
genomes (Deleo et al. Draft genomes were2014; Snitnik et al., 2012; Liu et al., 2012), 158 
respectively and uploaded to the RAST server (http://rast.nmpdr.org/) and BASYs Server for 159 
functional annotation (Van Domselaar et al., 2005).  160 
Antimicrobial resistance gene and replicon content were detected using the ResFinder 161 
(Zankari et al., 2012) and PlasmidFinder (Carattoli et al., 2014) tools 162 
(https://cge.cbs.dtu.dk/services/). 163 
Virulence genes were identified using the BIGSdb-Kp database, at the Institut Pasteur 164 
(http://bigsdb.pasteur.fr/klebsiella/klebsiella.html) and phage sequences using the PHAST 165 
prediction tool (http://phast.wishartlab.com/). Capsular type was deduced by comparing 166 
the sequence of the wzi gene with those previously described (Brisse et al., 2013). 167 
Genome comparative analysis 168 
The 48-IT was used as reference genome at the SEED Viewer version 2.0 169 
(http://rast.nmpdr.org/seedviewer.cgi) for comparison with the other ST307 WGSs, to 170 
identify genetic differences occurring within the ST307 clone (Figure S1).  171 
Using the SEED Viewer version 2.0, and the MAUVE comparison tool, the 48-IT WGS was 172 
compared with the Kp NJST258_2 (NZ_CP006918), KPNIH1 (NZ_ CP008827) and HS11286 173 
(CP003200) reference genomes (Deleo et al. 2014; Snitnik et al., 2012; Liu et al., 2012). 174 
Results were reconfirmed comparing three representative ST307 strains with the three 175 
reference genomes (Figures S2 and S3).  176 
The cut off defining the major differences was: presence or absence (<70% aminoacid 177 
identity) of at least >5 consecutive CDSs (Table S2). Analysis of the major differences was 178 
manually curated and the respective DNA sequence was analysed by BlastN 179 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi) against the NCBI database.  180 
Core genome MLST was performed using the BIGSdb tool (Jolley & Maiden, 2010) installed 181 
at Institut Pasteur (http://bigsdb.pasteur.fr) based on the 634-gene strict core-genome 182 
MLST scheme of Bialek-Davenet et al., 2014. Classification of strains was performed by the 183 
neighbor-joining method using as distance matrix, the proportion of mismatches among 184 
allelic profiles of the strict core genome MLST scheme (Gouy et al., 2010). 185 
The integration site of Integrative Conjugative Elements (ICEs) was obtained comparing in 186 
silico the 48-IT and H151440671-UK sequences with the genome of the K. pneumoniae 187 
strain CAV1193 (CP013322; Sheppard et al., 2016), which does not carry the yersiniabactin 188 
ICE.  ICE groups and tRNA-ASN integration sites followed the classification proposed by 189 
Marcoleta et al., 2016.   190 
Plasmid reconstruction  191 
Plasmid pKPN-307 type A and pKpQIL-307 plasmids were assembled using the DNA was 192 
purified from strain 48-IT and used to transform Escherichia coli DH5α chemically 193 
competent cells (Invitrogen), selecting on Luria–Bertani agar plates (Sigma), containing 194 
ampicillin (50 µg/ml), obtaining blaKPC-3-positive transformants.  195 
Plasmid contigs obtainedwere tested by the GS-FLX gsAssembler software.ResFinder 196 
(Zankari et al., 2012) and PlasmidFinder (Carattoli et al., 2014) tools 197 
(https://cge.cbs.dtu.dk/services/). The assembly of the  contigs was initially done in silico by 198 
using the 454 ReadStatus output file, generated by the gsAssembler software (Roche 199 
Diagnostics), identifying reads overlapping adjacent contigs. The assembly was confirmed 200 
and verified by PCR followed by Sanger DNA sequencing. pKPN-307 type A and pKpQIL-307 201 
were used as DNA sequence reference for in silico identification and assembly of contigs in 202 
the other ST307 genomes. Plasmid scaffolds showing pair-end overlapping were assembled. 203 
The plasmid assembly was confirmed and verified by PCR-based gap closure for plasmids 204 
identified in CIV4-IT, KL-49-CO and KH-43-CO strainsPlasmid pKpQIL carrying blaKPC-3 was 205 
split in 9 contigs and the complete plasmid sequence was reconstructed by PCR-based gap 206 
closure method using the 48-IT transformant as DNA template. The pKpQIL-307 of 48-IT 207 
strain was submitted in GenBank as prototype of this plasmid type.  208 
Plasmids pKPN-307 types B, C and D were obtained from H151440672-UK, H151400611-UK, 209 
and KL-49-CO genomes, respectively. Plasmids of IncN types A, B and C were assembled 210 
from the genomes of KL-49-CO, H151440671-UK and H151400611-UK, respectively.Thirty 211 
contigs were identified relative to a pKPN3-like plasmid. The complete sequence was 212 
reconstructed by PCR, closing all the gaps and reconfirming the plasmid map, which was 213 
named pKPN-307 type A and submitted to GenBank as prototype of this plasmid type. Apart 214 
strain 48-IT, plasmid pKPN-307 type A was identified at 99% identity and 100% coverage in 215 
genomes H154440769-UK (43 contigs), KH-43-CO (20 contigs) and KL-49-CO (19 contigs), 216 
respectively. Predicted plasmid assembly in these strains was verified checking pair-end 217 
overlapping and confirmed by PCR-based closure method. 218 
In the other ST307 genomes, plasmid contigs were identified by ResFinder, PlasmidFinder, 219 
and BlastN against the pKPN-307, pKpQIL-307, and R46 IncN plasmids used as reference 220 
sequences. The assembly of plasmid contigs predicted by alignment with plasmid references 221 
was checked for pair-end overlapping, and some prototypes were confirmed by PCR-based 222 
gap closure method. In detail, plasmid pKPN-307 type B was  obtained from H151440672-UK 223 
(21 contigs, selected as prototype pKPN-307 type B for submission in GenBank), 224 
H151300628-UK (22 contigs), H151400611-UK (20 contigs) and H151440672-UK (21 contigs), 225 
respectively. Plasmids pKPN-307 type C and D were  obtained from H150820806-UK (62 226 
contigs) and CIV4-IT (23 contigs), respectively and submitted in GenBank.  Plasmids of IncN 227 
types A, and C were fully assembled for GenBank submission from the genomes of KL-49-CO 228 
(6 contigs) and H151400611-UK (10 contigs), respectively. Plasmid IncN type B was 229 
assembled from H151440671-UK (8 contigs, selected as prototype IncN type B for 230 
submission in GenBank), H151300628-UK (12 contigs), H151400610-UK (11 contigs) and 231 
H151440672-UK (15 contigs), respectively. Plasmids pTetA and pTetA-QnrB1 were in single 232 
scaffolds with complementary pair-ends, in the genomes of H151440672-UK and KH-43-CO 233 
strains, respectively.  234 
Manual annotation of complete plasmid sequences was done using Artemis Version 8 235 
(Sanger Institute) in combination with a pairwise alignment, performed by BLASTP 236 
homology search (http://blast.ncbi.nlm.nih.gov/Blast.cgi).  237 
Serum resistance   238 
Serum resistance assays were performed using 100 µl of K. pneumoniae overnight bacterial 239 
LB liquid culture, diluted to the final concentration of 1.5x104 cells/ml, mixed with 300 µl of 240 
fresh, non-heated human sera obtained from healthy volunteers.  A pool of three sera from 241 
different volunteers was used for every experiment. The 1:3 bacteria-sera volume ratio 242 
mixture was incubated at 37 °C and aliquots of 100 µl were plated on LB agar plates at T0 243 
and after 30, 60 and 120 min of incubation with sera. Plates were incubated overnight at 37 244 
°C and viable cell counts were determined. The assays were repeated three times using 245 
three different pools of sera obtained from different volunteers. 246 
PCR analysis of ST307 specific features. 247 
Specific features identified in the ST307 genomes were screened for by PCR in the entire 248 
collection of isolates listed in Table 1, using primer pairs listed in the Supplementary Table 249 
2S3. PCR assays were performed on total DNAs extracted by Macherey Nagel kit, using the 250 
following PCR conditions: 1 cycle of denaturation at 94°C for 5 min, followed by 30 cycles of 251 
denaturation at 94°C for 1 min, annealing at temperature indicated in Supplementary 252 
Table1 for 30 s and elongation at 72°C for 1 min. The amplifications were concluded with an 253 
extension program of 1 cycle at 72°C for 5 min. The blaCTX-M and wzi genes were screened 254 
using previously described primers and conditions (Brisse et al., 2013; Carattoli et al., 2008) 255 
PCR products were fully sequenced.  256 
Plasmid typing was performed using the PCR-Based Replicon Typing Kit (PBRT-KIT, 257 
DIATHEVA, Srl, Fano, IT). 258 
 259 
RESULTS 260 
Whole-genome sequencing of KPC-Kp ST307 261 
A total of 24 ST307 isolates from Italy, Colombia and UK were studied. Twelve isolates, 262 
representative of our collections were sequenced (Suppl. Table 1).  263 
Cluster analysis based on 634 strict core-genome MLST genes demonstrated the clear 264 
phylogenetic distinction of the ST307 genomes from previously analyzed isolates, 25, 28 265 
showing that they represent a unique sub-lineage (or clonal group) of K. pneumoniae very 266 
distant from the two ST258 clades (Fig. 1). .  267 
WGS comparative analysis 268 
Comparative analysis of strains from Italy, Colombia and UK evidenced that  the major 269 
differences in the WGSs of ST307 were in antimicrobial resistance gene complement 270 
(resistome), plasmid and phage gene content (mobilome).   271 
The ST307 core genome was highly conserved among strains, while different variants of 272 
plasmids and Integrative Conjugative Elements (ICEs) were detected (Figure S1). A total of 273 
4745 common genes and 637 accessory genes, present in at least one of the 12 sequenced 274 
isolates, were identified. Among them, 202 were hypothetical proteins with unknown 275 
function and 83 were phage-associated proteins. The major differences among the genomes 276 
were in antimicrobial resistance gene complement (resistome) and plasmid and phage gene 277 
content (mobilome).  278 
Comparative analysis using both Seed Viewer (BlastP-based comparison, Figure S2) and 279 
MAUVE alignment tool (BlastN-based alignment, Figure S3) performed among the 280 
chromosome of 48-IT, NJST258_2 (NZ_CP006918), KPNIH1 (NZ_ CP008827) and HS11286 281 
(CP003200) genomes, identified 16 major regions of discontinuity (Table S2). Regions that 282 
were unique of 48-IT, being absent in the other three reference genomes encoded capsules, 283 
LPS modification, fimbriae, secretion and efflux systems and were analysed in detail.  284 
 ST307 resistome 285 
EighteenSixteen strains were CTX-M-15-positives (all the Colombian, 7/12 Italian and 5/8 UK 286 
isolates) and, among them 11nine were KPC-3 and seven KPC-2 producers (Table 1). The 287 
resistance content showed thatblaKPC-3 gene was detected in all the Italian isolates had the 288 
blaKPC-3 gene, comprising alsostrains, in the UK isolatestrain imported from Italy, the UK 289 
isolates had the and in two strains from Colombia. The blaKPC-2 gene, while the was detected 290 
in all strains from UK and in two Colombian isolates had both types..  Most of the strains 291 
carried additional acquired resistance genes, such as blaCTX-M-15, blaTEM, blaOXA, aac(3)-IIa, 292 
aac(6’)Ib-cr , qnrB, tet(A), strAB, sul2, dfrA14, and catB3, but the precise complement of 293 
resistance genes differed among the isolates. The blaSHV-28, oqxAB and fosA, previously 294 
described as intrinsic resistance genes in K. pneumoniae, were detected in all genomes 295 
(Table 2). 296 
ST307 mobilome – plasmids 297 
Plasmids were classified into four major groups on the basis of replicon and resistance gene 298 
content: 299 
i) The KPC-carrying plasmids.  300 
The blaKPC-3 gene was always located on pKpQIL-like plasmids, 116,499 bbbp in 301 
size, highly similar to those previously described in the CG258 clones (Leavitt et 302 
al., 2010; Chen et al., 2014) and characterized by the presence of two replicons 303 
(FIIk2, FIB-pKpQIL).  The blaKPC-2 gene was located on three different plasmids: 304 
pKpQIL-like, IncN and untypable (in the KH-43-CO strain) plasmids (Table 3). 305 
Three types of IncN plasmids were identified and named types A, B and C (Gootz 306 
et al., 2009). Type A was detected in a Colombian strain while types B and C were 307 
found in isolates from UK.  308 
IncN type A was 54,345 bp in size, showed the integration of the Tn5403-309 
ΔISKpn6- blaKPC-2 –ISKpn7 transposon into a class 1 integron, containing the 310 
aac(6’)Ib-cr gene cassette located close to the uvp1 resolvase gene.   311 
IncN type B was 52,848 bp in size, showed the integration of a composite blaKPC-2 312 
gene environment, including IS26, ISEcp1, a portion of Tn2-blaTEM-1 transposon 313 
and the deleted ΔISKpn6 element of Tn4401. This structure was integrated within 314 
the nuc gene of the IncN plasmid.  315 
IncN type C was 55,680 bp in size and was identical to type B except that it 316 
carried a Δ3’CS-class 1 integron carrying the dfrA14 gene cassette close to the 317 
uvp1 resolvase gene.  318 
ii) pKPN-307 plasmids.  319 
Four types of pKPN-307 were identified and named type A to D (Table 1, Fig. 3).  320 
Type A pKPN-307 was 227,989 bp in size, contained two replicons (FIIk7, FIB-321 
pKPN3), and a multi-drug resistance region (MDR) of 38 Kb carrying blaCTX-M-15, 322 
blaTEM-1B, blaOXA-1, aac(3)-IIa, aac(6’)Ib-cr , qnrB1, strAB, sul2, dfrA14, and catB3 323 
genes and arsenic, copper and silver resistance clusters. Five putative virulence-324 
encoding clusters were identified: the lac operon, the Fec-like iron(III) dicitrate 325 
transport system, a glutathione ABC-transport system (Garcia-Fernandez et al., 326 
2012) a novel urea ABC-transport system and a novel cluster for glycogen 327 
synthesis. The urea transport system included UrtA (urea binding protein), UrtB 328 
(urea permease), UrtC (urea transporter) and AmiF (formamidase). The glycogen 329 
synthesis cluster included a 4-alpha-glucan branching enzyme, glucose-1-330 
phosphate adenylyltransferase, glycogen synthase, glycogen phosphorylase and 331 
phosphoglucomutase enzymes.  332 
Type B pKPN-307 was 133,069 bp in size, carried the FIB-pKPN3 replicon, arsenic 333 
and copper/silver resistance and the same MDR region as found in type A 334 
plasmid, but lacked a catB3 gene, qnrB and dfrA14 genes and the FIIk7 replicon 335 
and transfer locus. This plasmid carried a urea ABC-transport system and a partial 336 
glycogen synthesis cluster.glutathione ABC-transport system.  337 
Type C pKPN-307 was 212,319 bp in size. In this plasmid the virulence clusters, 338 
transfer and arsenic and copper/silver loci, and replicons were as found in type 339 
A, while the MDR region lacked the blaCTX-M-15, aac(3)-IIa, strAB and sul2 340 
resistance determinants.  341 
Type D pKPN-307 was 116,325 bp in size. Transfer region and replicons were as 342 
in type A plasmids but the MDR region carried only the blaTEM-1B, blaOXA-1, 343 
aac(6’)Ib-cr, qnrB1 and dfrA14 genes and a partial copper/silver resistance 344 
determinant. None of the five virulence clusters identified in type A plasmids 345 
were detected on this plasmid variant.   346 
iii) The pTet-plasmids. The Tn1721::tet(A) element was identified on ~5 Kb plasmids 347 
in two strains from the UK and in KL-49-CO from Colombia  (Table 1). In strain 348 
KH-43-CO a tet(A)-qnrB1 plasmid of 13,262 bp was detected.  349 
iv) Other large plasmids.  350 
FIB-M, HIB-M and R replicons were identified in the genomes of two UK isolates 351 
(Table 1). It was not possible to get complete assembly of plasmids carrying these 352 
replicons and to link them to any resistance gene(s) because of the short contigs 353 
generated by short-read WGS technology and the lack of a proper reference 354 
plasmid for the assembly. 355 
The 12 ST307 isolates that were not sequenced were screened by PCR to detect the most 356 
relevant plasmid-mediated features identified (Table 1). Overall WGS and PCR results 357 
confirmed the frequent association of pKpQIL with KPC-3 and of an IncN plasmid with KPC-2. 358 
CTX-M-15 was associated with the pKPN-307 plasmids. Type A pKPN-307 was the most 359 
diffused pKPN-307-like plasmid, present in strains from Italy, Colombia and the UK; pKPN-360 
307 types B and C were detected in Italian and UK isolates, whereas pKPN-307 type D was 361 
present only in two Italian isolates (CIV57-IT and CIV4-IT).  362 
 ST307 mobilome - prophages, phages, and integrative conjugative elements  363 
Six different prophages were identified in the ST307 genomes, with ф1 and ф2 the most 364 
prevalent, being detected in 10/12 genomes. One extrachromosomal phage was identified 365 
in strain 48-IT (Table 2, Fig. S1). 366 
Integrative conjugative elements (ICEs) associated with the cluster encoding the 367 
yersiniabactin virulence trait (Schubert et al., 2004; Lin et al., 2008) were found in 8/12 368 
genomes (Table 2). Two yersiniabactin cluster variants were identified, designated ICE-YB-369 
Type A and B, respectively. Type A and B differed in ybt, irp1, irp2, and fyuA alleles (Suppl. 370 
Table 3S4) and the ICE structure. Both ICEs were constituted of a Type IV secretion system, 371 
(T4SS), mobA and mobB genes but showed a different assortment of associated ORFs, 372 
encoding conserved or hypothetical proteins. The two ICEs also showed integration into two 373 
different tRNA-Asn sites (Menard & Grossman, 2013) within their respective K.  (Lin et al., 374 
2008). Type A was 99% identity, 96% coverage with the group VI ICE, as previously described 375 
in HS11286 reference genome (Marcoleta et al., 2016). Type B showed 98% identity, 86% 376 
coverage with group VI, including a 8 Kb region, encoding restriction-methylation enzymes, 377 
ABC transport system and hypothetical  proteins. Only four matches (SKGH01-ST147, 378 
CP015500.1; CAV1016-ST45, CP017934.1; RJF293-ST374, CP014008.1; E. coli ED1a, 379 
CU928162.2) among hundreds of genomic sequences available in public sequence databases 380 
were identified by BLASTN showing homology with this 8 Kb terminal portion of the ICE, 381 
suggesting that this is a new and rare type of ICE element.  382 
The two ICEs also showed integration into two different tRNA-Asn1B (Type A) and tRNA-383 
Asn1D (Type B) sites (Menard & Grossman, 2013; Marcoleta et al., 2016) within their 384 
respective K. pneumoniae genomes (Fig. 4).  385 
ST307 fimbriae  386 
A region of ~13 Kb was unique toidentified in the ST307 clone and encoded a π-fimbrial 387 
chaperone/usher pathway, including the fimbrial subunit, the usher and chaperone 388 
proteins. π-fimbriae were previously described in uropathogenic, piliated Escherichia coli 389 
(Nuccio & Baumler, 2007). PCR analysis demonstrated that this π-fimbrial cluster was 390 
present in all ST307 isolates in our collection (Table 1). This cluster was not present in the 391 
ST258 and ST11 genomes, and by BLASTN on the entire GenBank database it was identified 392 
only in fifteen  Kp genomes, belonging to different STs (ST147, ST273, ST392, ST86, ST278, 393 
ST37, ST941 and ST442). 394 
Eight additional fimbriae-encoding clusters and the mrk cluster coding for type 3 pili were 395 
also identified in all ST307 genomes (Suppl. Table 3). 396 
 These fimbriae are not unique of the ST307 clone being described in many other Kp 397 
genomes (Holt et al., 2015) ST307 capsular loci and resistance to serum complement 398 
We identified the wzi-173 allele, previously associated with the KN2 capsular type (Follador 399 
et al., 2016; Pan et al., 2015) in 20/24 ST307 isolates (Table 1). In the genome of CIV4-IT, 400 
representative of the four wzi-negative strains, an ISKpn7 element disrupted the capsular 401 
cluster at the kpb6 gene. The remaining portion of the cluster was not detected within the 402 
genome, suggesting that integration of the insertion sequence was followed by a deep 403 
rearrangement causing the deletion of approximately 12 ORFs of the cps-cluster (ΔCp1 in 404 
Fig. S2).  405 
5, panel A). Beside ST307, the wzi173 was also identified in two Kp isolates in the BIGSdb-Kp 406 
database (http://bigsdb.pasteur.fr/klebsiella/klebsiella.html) belonging to ST1272 (KP-11 407 
and KP-7) isolated in North America from humans. A second complete cluster potentially 408 
encoding a different capsular type was identified in all ST307 genomes (Cp2 in Fig. S2).  This 409 
cluster was highly homologous to capsular clusters identified in Enterobacter aerogenes.S5) 410 
within a 14 Kb region of discontinuity with respect to the NJST258, HS11286 and KPN1H1 411 
reference genomes.  This cluster showed the best homology to capsular clusters identified 412 
in Enterobacter aerogenes (93% nucleotide identity with E. aerogenes strain CAV1320, 413 
CP011574). In all the other Kp genomes two hypothetical proteins are encoded at this site, 414 
while this cluster is present (93% nucleotide identity) in the genome of Klebsiella 415 
quasipneumoniae strain ATCC 700603 (CP014696.2).  416 
Isolates carrying both Cp1 and Cp2 capsular clusters and those showing the deleted Cp1 417 
cluster were analyzed for complement resistance using a pool of three different fresh 418 
human sera from healthy volunteers at a final concentration of 20%.  ST258 and ST101 419 
strains were also tested in the same experiments as internal comparators of the 420 
experiments. Results showed that ST307 isolates endowed with intact Cp1 and Cp2 clusters 421 
were more resistant to complement than ST258, but both were more susceptible than 422 
ST101. However, ISKpn7-mediated disruption of the Cp1 cluster strongly affected the 423 
complement resistance of K. pneumoniae, despite the presence of Cp2, showing 2 Logs of 424 
reduction of cfu in the first hour, and 4 Logs of reduction after two hours of incubation with 425 
human sera (Fig. 5).  426 
  427 
 Other features 428 
Other discontinuity regions were detected comparing ST307 with the reference ST258 and 429 
ST11 genomes, encoding sugar transport via the phosphoenolpyruvate phosphotransferase 430 
system, antirestriction proteins, toxin-antitoxin systems, ethanolamine utilization  and other 431 
functions, whose role in fitness and virulence of ST307 cannot be predicted (Table S2).  Of 432 
note, a Type VI secretion system (T6SS) was identified in all ST307 and by BLASTN only in 433 
three other Kp genomes  (CAV1016-ST45, CP017934; MGH 78578-ST38, CP000647; 434 
Kp52.145-ST66, FO834906), and corresponded to the cluster II T6SS, previously described in 435 
MGH 78578 (Sarris et al., 2011). ST307 also carried the cluster for the metabolism of the 4-436 
hydroxyproline that exists in collagen, and most bacteria cannot metabolize this 437 
hydroxyamino acid (Watanabe et al., 2012). This was detected by BlastN in other 17 Kp 438 
genomes in GenBank, the majority belonging to the ST147 clone.  439 
DISCUSSION 440 
KPC-Kp ST307 is a novel lineage that has potential to become an epidemic or ‘high risk’ 441 
clone. Our analysis revealed that ST307 represents a distinctive clonal group and 442 
demonstrates that the main carbapenemase KPC was acquired through horizontal transfer 443 
of plasmids. In each country of isolation, the most frequent KPC variant on its respective 444 
plasmid type (i.e., pKpQIL-KPC-3 and IncN-KPC-2) moved into ST307 (Garcia-Fernandez et al., 445 
2012; Findlay et al., 2016; Cheng et al., 2016; Snitkin et al., 2012). The acquisition of KPC 446 
was probably subsequent to that of CTX-M-15 and this event occurred independently in 447 
different countries after the spread of ST307, as deduced by the fact that strains had distinct 448 
KPC plasmids but related CTX-M-15 carrying plasmids.  449 
We found major characteristics that canmay provide an advantage to this clone in 450 
adaptation to the hospital environment and in the human host. Plasmid pKPN-307 is likely 451 
one of the crucial players in the evolution of this clone. The largest variant of this plasmid 452 
identified in this study (type A) carried five putative virulence clusters: the lacIZY operon, 453 
the Fec-like iron (III) dicitrate transport and the glutathione ABC-transport system, the urea 454 
transport system and the cluster for glycogen synthesis. In Escherichia coli, 455 
glycogen synthesis is regulated by the stress sigma factor RpoS and is considered one of the 456 
possible adaptive responses to long-term survival and growth in environments outside the 457 
host (Somorin et al., 2016). It can be hypothesized that plasmid-mediated glycogen 458 
synthesis may help ST307 isolates survive under limited nutrient availability and that the 459 
urea transport system may facilitate colonization of the urinary tract by this clone. Urinary 460 
tract colonization may also be sustained by the unusual π-fimbria identified in all of our 461 
ST307 genomes. This kind of fimbria is characteristic of uropathogenic E. coli (Menard & 462 
Grossman, 2013).ST307 also carries the yersiniabactin siderophore mobilized by an ICE, 463 
previously recognized as a relevant and frequent virulence factor in Kp (Schubert et al., 464 
2004; Holt et al., coli (Menard & Grossman, 2013).2015).  465 
ST307 also carries a yersiniabactin siderophore mobilized by an ICE, recognized by one 466 
major virulence factor in Kp (Schubert et al., 2004; Holt et al., 2015). 467 
Two different capsular loci were identified in ST307. One is unique to ST307, characterized 468 
by the wzi123wzi-173 allele, the second cluster was previously detected inis homologous to 469 
the Enterobacter spp. genomes and has never been described in Kp. Capsules are used by 470 
microbes to escape the host immune response has been associated with biofilm formation, 471 
protection from desiccation and contributes to serum survival (Miajlovich et al., 2014; 472 
Doorduijn et al., 2016). WeSince there are not functional studies on cps2, we cannot predict 473 
the role of this addiction capsular locus in ST307 genome. However, we demonstrated that 474 
capsulated ST307 isolates endowed with the two functional clusters were more resistant to 475 
serum complement than ST258 isolates. Overall, some of the genetic features identified in 476 
the genome ST307 genome despite the lack of a formal functional validation, are interesting 477 
and rare and may contribute to increasedincrease fitness, persistence and adaptation of this 478 
clone in the hospital environment and in the human host and shed light on the potential 479 
epidemiological success of ST307...  480 
 481 
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FIGURES LEGENDS 727 
Figure 1. Unrooted neighbor-joining tree of K. pneumoniae core genome  728 
Unrooted neighbor-joining tree is based on the proportion of mismatches among allelic 729 
profiles of the strict core genome MLST scheme. Numbers at the tip of branches are 730 
sequence types. The positions of ST307 and the two ST258 clades are indicated by orange 731 
and green boxes, respectively 732 
Figure 2. KPC-positive plasmids identified in ST307 733 
White arrows indicated plasmid scaffold genes and their direction of transcription. The 734 
locus Tra is indicated by a squared white arrow with capitol letters indicating the 735 
respective tra genes (i.e. J: traG, G; traF, F; traO, O etc..). Resistance genes are indicated 736 
by orange coloured arrows. Transposon-related genes [tnpA, tnpR, tnpM], class 1 737 
integrase and insertion sequences are indicated by red arrows. Other genes are indicated 738 
by coloured boxes as follows: violet, replicase genes; grey, restriction enzyme and DNA 739 
methylase genes; green, ccg cluster; blue fipA and nuc genes .   740 
Figure 3. Variant pKPN-307 plasmids identified in ST307 741 
White arrows indicate plasmid scaffold genes and their direction of transcription. The locus 742 
Tra is indicated by a squared white arrow with capital letters indicating the respective tra 743 
genes (i.e. J: traG, G; traF, F; traO, O etc..). Resistance genes are indicated by orange 744 
coloured arrows. Transposon-related genes [tnpA, tnpR, tnpM], class 1 integrase and 745 
insertion sequences are indicated by red arrows. Other genes are indicated by colored boxes 746 
as follows: violet, replicase genes; green, clusters encoding putative virulence determinants.    747 
Figure 4. Integrative Conjugative Elements mobilizing the Yersiniabactin cluster 748 
Type A ICE (group VI as defined by Marcoleta et al., 2016) identified in strain 48-IT and type 749 
B ICE (group VI-like) identified in strain H151440671-UK are drawn indicating their 750 
integration site with respect to the tRNA genes (tRNA Asn1A, 1B, 1C and 1D as described in 751 
Marconeta et al., 2016) as detected in the complete genome sequence of strain CAV1193 752 
that does not contain ICEs. Arrows indicate genes and their direction of transcription. 753 
Colours indicate clusters encoding the yersiniabactin system (brown), Type IV secretion 754 
system (green), hyphotetical proteins (blue) and other ICE associated  genes (yellow), 755 
respectively. Abbreviations: R:Restriction, M: Methylation; RT: Reverse Transcriptase.   756 
Figure 5. Complement resistance of ST307 757 
Bars represent serum resistance results performed using fresh, non-heated human sera 758 
obtained from healthy volunteers on ST307 strains 48-I (blue), representative of  strains 759 
carrying both Cp1 and Cp2 capsular loci, and CIV4-IT (white) as representative of strains 760 
carrying ΔCp1 and Cp2 cluters. As comparators strain ST258 (green) and ST101 (orange) 761 
were also tested. Colony-forming units were measured immediately after 1:3 mixture with 762 
sera (T0) and after 30 (T30), 60  (T60) and 120 (T120) min of incubation.  763 
 764 
Table 1. Characteristics and features of the ST307 K. pneumoniae isolates from three countries 
Straina Country Carbapenemase 
and ESBL 
Plasmids Capsule π-fimbria 
Replicons Urea Glycogen pKPN307 
type 
pKpQIL 
KPC-3 
IncN 
KPC-2 
type 
Cp1 
wzi 
Cp2 
48-IT IT KPC-3 CTX-M-15 FIIK,FIBK pos pos A pos neg 173 pos pos 
CIV2-IT IT KPC-3 CTX-M-15 FIIK,FIBK pos pos A pos neg 173 pos pos 
CIV10-IT IT KPC-3 CTX-M-15 FIIK,FIBK pos pos A pos neg 173 pos pos 
VSC1-IT IT KPC-3 CTX-M-15 FIIK,FIBK pos pos A pos neg 173 pos pos 
CIV13-IT IT KPC-3 CTX-M-15 FIIK,FIBK pos pos A pos neg 173 pos pos 
CIV66-IT IT KPC-3 CTX-M-15 FIIK,FIBK pos neg B pos neg 173 pos pos 
CIV65-IT  IT KPC-3 CTX-M-15 FIIK,FIBK pos neg B pos neg 173 pos pos 
KH-24-CO CO KPC-3 CTX-M-15 FIIK,FIBK pos pos A neg neg 173 pos pos 
KH-37-CO CO KPC-3 CTX-M-15 FIIK,FIBK pos pos A neg neg 173 pos pos 
KH-43-CO CO KPC-2 CTX-M-15 N, FIIK,FIBK pos pos A neg neg 173 pos pos 
KL-49-CO CO KPC-2 CTX-M-15 N, FIIK,FIBK pos pos A neg A 173 pos pos 
H151300628-UK UK KPC-2 CTX-M-15 N,FIIK,FIBK pos neg B neg B 173 pos pos 
H151400610-UK UK KPC-2 CTX-M-15 N, FIIK,FIBK pos neg B neg B 173 pos pos 
H151400611-UK UK KPC-2 CTX-M-15 N, FIIK, FIBK, 
FIBM,HIBM 
pos neg B neg C 173 pos pos 
H151440672-UK UK KPC-2 CTX-M-15 N, FIIK,FIBK pos neg B neg B 173 pos pos 
H154440769-UK UK KPC-2 CTX-M-15 FIIK,FIBK pos pos A pos neg 173 pos pos 
H150820806-UK UK KPC-2 neg FIIK,FIBK pos pos C pos neg 173 pos pos 
CIV57-IT IT KPC-3 neg FIIK,FIBK neg neg D pos neg 173 pos pos 
H155360912-IT UK KPC-3 neg FIIK,FIBK,R neg neg neg pos neg 173 pos pos 
H151440671-UK UK KPC-2 neg N neg neg neg neg B 173 pos pos 
CIV4-IT IT KPC-3 neg FIIK,FIBK neg neg D pos neg neg pos pos 
CIV78-IT IT KPC-3 neg FIIK,FIBK pos pos C pos neg neg pos pos 
21-IT IT KPC-3 neg FIIK,FIBK pos pos C pos neg neg pos pos 
VSC21-IT IT KPC-3 neg FIIK,FIBK pos neg B pos neg neg pos pos 
a Whole Genome Sequencing was performed for underlined strains  
  
 
Table 2. Resistome, Integrative Conjugative Elements, prophages and phages in ST307 genomes  
Strain Beta-lactamases Aminoglycosides  Quinolones Others 
 
ICE-
YB 
 
Prophages Phage 
 
48-IT blaKPC-3,  blaCTX-M-15,  
blaTEM-1B,  blaOXA-1, 
blaOXA-9, blaSHV-28 
strA, strB, aac(3)-IIa, 
aac(6’)Ib-cr 
qnrB1, 
oqxAB  
sul2, dfrA14, 
catB3, fosA 
A Ф1 Ф2c     Ф48 
CIV4-IT blaKPC-3, blaTEM-1A,  
blaOXA-1, blaOXA-9,  
blaSHV-28 
aac(6’)Ib-cr qnrB1, 
oqxAB  
dfrA14, 
catB3, fosA 
A Ф1 Ф2c      
KH-43-CO blaKPC-2,  blaCTX-M-15,  
blaTEM-1B,  blaOXA-1,  
blaSHV-28 
strA, strB, aac(3)-IIa, 
aac(6’)Ib-cr 
qnrB1, 
oqxAB  
sul2, dfrA14, 
tetA, catB3, 
fosA 
neg Ф1 Ф2b  Ф4 Ф5 Ф6  
KL-49-CO blaKPC-2,  blaCTX-M-15,  
blaTEM-1B,  blaOXA-1,  
blaSHV-28 
strA, strB, aac(3)-IIa, 
aac(6’)Ib-cr 
qnrB1, 
oqxAB  
sul1, sul2, 
dfrA14, tetA, 
catB3, fosA 
neg Ф1 Ф2b Ф3 Ф4    
H150820806-UK blaKPC-2,  blaTEM-1A,   
blaOXA-1, blaOXA-9,  
blaSHV-28 
aac(6’)Ib-cr qnrB1, 
oqxAB  
dfrA14, tetA, 
catB3, fosA 
neg Ф1  Ф3 Ф4    
H154440769-UK blaKPC-2,  blaCTX-M-15,  
blaTEM-1B,  blaOXA-1, 
blaOXA-9, blaSHV-28 
strA, strB, aac(3)-IIa, 
aac(6’)Ib-cr 
qnrB1, 
oqxAB  
sul2, dfrA14, 
tetA, catB3, 
fosA 
neg Ф1       
H151300628-UK blaKPC-2,  blaCTX-M-15,  
blaTEM-1B,  blaOXA-1,  
blaSHV-28 
strA, strB, aac(3)-IIa, 
aac(6’)Ib-cr 
qnrB1, 
oqxAB  
sul2, dfrA14, 
tetA, fosA 
B Ф1 Ф2      
H151400610-UK blaKPC-2,  blaCTX-M-15,  
blaTEM-1B,  blaOXA-1,  
strA, strB, aac(3)-IIa, qnrB1, sul2, dfrA14, B Ф1 Ф2      
blaSHV-28 aac(6’)Ib-cr oqxAB  tetA, fosA 
H151400611-UK blaKPC-2,  blaCTX-M-15,  
blaTEM-1B,  blaOXA-1,  
blaSHV-28 
strA, strB, aac(3)-IIa, 
aac(6’)Ib-cr 
qnrB1, 
oqxAB  
sul2, dfrA14, 
tetA, fosA 
B Ф1 Ф2      
H151440672-UK blaKPC-2,  blaCTX-M-15,  
blaTEM-1B,  blaOXA-1,  
blaSHV-28 
strA, strB, aac(3)-IIa, 
aac(6’)Ib-cr 
qnrB1, 
oqxAB  
sul2, dfrA14, 
tetA, fosA 
B Ф1 Ф2      
H155360912-IT blaKPC-3,  blaTEM-1A,  
blaOXA-9,  blaSHV-28 
 oqxAB  fosA B  Ф2      
H151440671-UK blaKPC-2,  blaTEM-1B,  
blaSHV-28 
 oqxAB  fosA B Ф1 Ф2      
 
